Skip to content

Arcutis Biotherapeutics, Inc. ARQT Other Non-Current Assets

Other Non-Current Assets at other companies

Amgen logo
AmgenAMGN
$12.76B+12.0%
Incyte logo
IncyteINCY
$24.49M-18.8%
Celldex Therapeutics logo
Celldex TherapeuticsCLDX
$15.43M+48.3%
Arcus Biosciences logo
Arcus BiosciencesRCUS
$61M-14.1%
Ultragenyx Pharmaceutical logo
Ultragenyx PharmaceuticalRARE
$61M-2.2%
Kymera Therapeutics logo
Kymera TherapeuticsKYMR
$7.7M+132%

Other financials

Income statement

See full
Revenue$105.4M+60.1%
Gross profit$95.6M+67.7%
Operating income-$9.1M+62.9%
Net income-$11.3M+54.9%
EPS (diluted)-$0.09+55.0%

Balance sheet

See full
Cash & equivalents$35.1M-34.7%
Total debt$114.7M+3.5%
Total equity$189.6M+32.9%
Total assets$460.0M+33.7%

Cash flow

See full
Operating cash flow$2.2M+107%
CapEx--100%
Free cash flow$2.2M+107%

Valuation

See full
Market cap$3.29B+57.5%

Profitability

See full
Gross margin90.9%+2.5pp
Operating margin-12%-5.7pp
Net margin-13.9%-6.6pp
FCF margin-52.5%-21.9pp

Returns & leverage

See full
Return on equity-28.2%-13.0pp
Debt / equity0.6×-0.2×
Current ratio2.7×-0.9×

Where this comes from

Reported directly by Arcutis Biotherapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:OtherAssetsNoncurrent.

The official record: Arcutis Biotherapeutics, Inc.’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about Arcutis Biotherapeutics, Inc.'s other non-current assets.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Arcutis Biotherapeutics, Inc.'s other non-current assets?
Arcutis Biotherapeutics, Inc. (ARQT) reported other non-current assets of $2.3M in Q1 2026.
How has Arcutis Biotherapeutics, Inc.'s other non-current assets changed year-over-year?
Arcutis Biotherapeutics, Inc.'s other non-current assets increased by 285.2% year-over-year, from $596K to $2.3M.
What is the long-term trend for Arcutis Biotherapeutics, Inc.'s other non-current assets?
Over 5 years (2020 to 2025), Arcutis Biotherapeutics, Inc.'s other non-current assets has grown at a 78.6% compound annual growth rate (CAGR), from $78K to $1.42M.
What does other non-current assets mean?
Long-term assets not classified in specific categories — a catch-all for miscellaneous non-current assets.